ArticleBMC biotechnology2025

In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer.

Nigar Kantarci-Carsibasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.